The FDA has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, making the test the first to get signoff to aid in the early detection of the disease in the U.S.

In contrast to areas like breast cancer, where people at high risk of the disease can be offered preventative measures, there ...